Active substance
Teicoplanin
- SFDA 7
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| TARGOPLANIN 200 mg injection | 200 mg | Powder for injection · Intravenous use | 1 Vial | SAR 68.45 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| TEICO 200 mg Vial | 200 mg | Powder and solvent for solution for injection/infusion · Intramuscular and intravenous use | 1 Vial | SAR 55.40 | Generic · Prescription | LES LABORATOIRES MEDIS | Valid |
| TEICO 400 mg Vial | 400 mg | Powder and solvent for solution for injection/infusion · Intramuscular and intravenous use | 1 Vial | SAR 79.70 | Generic · Prescription | LES LABORATOIRES MEDIS | Valid |
| Ticopex | 200 mg | powder for solution for injection · Intravenous use | 1 Vial | SAR 61.60 | Generic · Prescription | MS Pharma Saudi (MSPS) | Valid |
| TARGOCID 200MG VIAL+DILUENT | 200 mg | Injection · Intravenous use | 1 Vial | SAR 84.25 | NCE · Prescription | SANOFI S.P.A.(MILAN) | Withdrawn by MAH · Not Marketed |
| TARGOCID 200MG VIAL+DILUENT | 200 mg | Solution · Intravenous use | 1 Vial | SAR 84.25 | NCE · Prescription | sanofi-aventis | Withdrawn by MAH · Not Marketed |
| TARGOPLANIN 400 mg injection | 400 mg | Powder for injection · Intravenous use | 1 Vial | SAR 136.90 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
ACUTE EXACERBATION OF BRONCHIECTASIS (NON-CYSTIC FIBROSIS); BACTERIAL SKIN INFECTIONS - PURULENT SKIN AND SOFT TISSUE INFECTIONS (CUTANEOUS ABSCESSES, FURUNCLES, CARBUNCLES); HOSPITAL AND VENTILATER ACQUIRED PNEUMONIA; INTRA-ABDOMINAL INFECTIONS; OSTEOMYELITIS; PERITONITIS
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Teicoplanin 200mg powder and solvent for solution for injection vials | £4.42 | 1 vial | 1 Oct 2026 |
| NHS Drug Tariff | Teicoplanin 400mg powder and solvent for solution for injection vials | £8.21 | 1 vial | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.